Dr. Erkut Borazanci, MD
Claim this profileHonor Health Research Institute
Area of expertise
Pancreatic Cancer
Erkut Borazanci, MD has run 11 trials for Pancreatic Cancer. Some of their research focus areas include:
Solid Tumors
Erkut Borazanci, MD has run 5 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
HonorHealth Research Institute
HonorHealth
Clinical Trials Erkut Borazanci, MD is currently running
Early Detection
for Pancreatic Cancer
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.
Recruiting
1 award
N/A
10 criteria
PEEL-224
for Cancer
This trial is testing PEEL-224, a new drug, in patients with advanced solid tumors. The drug aims to block an enzyme that cancer cells need to grow, potentially slowing down or stopping the cancer.
Recruiting
1 award
Phase 1
More about Erkut Borazanci, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Erkut Borazanci, MD has experience with
- Gemcitabine
- Botensilimab
- Lurbinectedin
- HCW9218
- Minnelide™ Capsules
- SM08502
Breakdown of trials Erkut Borazanci, MD has run
Pancreatic Cancer
Solid Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erkut Borazanci, MD specialize in?
Erkut Borazanci, MD focuses on Pancreatic Cancer and Solid Tumors. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Erkut Borazanci, MD currently recruiting for clinical trials?
Yes, Erkut Borazanci, MD is currently recruiting for 3 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Erkut Borazanci, MD has studied deeply?
Yes, Erkut Borazanci, MD has studied treatments such as Gemcitabine, Botensilimab, Lurbinectedin.
What is the best way to schedule an appointment with Erkut Borazanci, MD?
Apply for one of the trials that Erkut Borazanci, MD is conducting.
What is the office address of Erkut Borazanci, MD?
The office of Erkut Borazanci, MD is located at: Honor Health Research Institute, Scottsdale, Arizona 85258 United States. This is the address for their practice at the Honor Health Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.